Loading...
XSHE300753
Market cap311mUSD
Jan 10, Last price  
18.14CNY
1D
-8.38%
1Q
39.54%
IPO
16.35%
Name

Jiangsu Apon Medical Technology Co Ltd

Chart & Performance

D1W1MN
XSHE:300753 chart
P/E
276.24
P/S
5.42
EPS
0.07
Div Yield, %
0.00%
Shrs. gr., 5y
5.97%
Rev. gr., 5y
7.21%
Revenues
422m
+30.38%
120,351,148153,515,561198,301,574246,922,317298,033,812379,647,097443,076,112461,210,894323,808,133422,170,460
Net income
8m
31,383,81528,898,90847,703,31857,921,51470,089,798102,343,46996,958,58254,063,72808,277,352
CFO
-22m
33,493,14238,077,49060,968,92167,075,96678,127,06877,590,76183,339,49918,286,4630-22,394,687
Dividend
Jun 03, 20240.065 CNY/sh
Earnings
May 20, 2025

Profile

Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. Its principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers in the field of nasal care. Jiangsu Apon Medical Technology Co., Ltd. was founded in 2001 and is headquartered in Nantong, China.
URL
https://www.apon.com.cn/
IPO date
Dec 13, 2018
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
422,170
30.38%
323,808
-29.79%
Cost of revenue
361,589
363,824
Unusual Expense (Income)
NOPBT
60,582
(40,016)
NOPBT Margin
14.35%
Operating Taxes
5,359
Tax Rate
8.85%
NOPAT
55,223
(40,016)
Net income
8,277
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
39,238
33,844
Long-term debt
61,317
69,059
Deferred revenue
1,904
Other long-term liabilities
1,804
2
Net debt
(176,882)
(250,192)
Cash flow
Cash from operating activities
(22,395)
CAPEX
(30,731)
Cash from investing activities
(27,136)
Cash from financing activities
1,674
23,917
FCF
(18,376)
17,895
Balance
Cash
201,896
249,252
Long term investments
75,540
103,844
Excess cash
256,328
336,905
Stockholders' equity
324,009
356,457
Invested Capital
512,568
413,124
ROIC
11.93%
ROCE
7.88%
EV
Common stock shares outstanding
125,987
126,056
Price
17.17
-4.98%
18.07
-10.94%
Market cap
2,163,199
-5.03%
2,277,834
-10.94%
EV
1,987,309
2,028,424
EBITDA
79,012
(20,427)
EV/EBITDA
25.15
Interest
3,072
2,474
Interest/NOPBT
5.07%